Centre Hospitalier St Anne
100
32
34
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.0%
5 terminated/withdrawn out of 100 trials
81.5%
-5.0% vs industry average
7%
7 trials in Phase 3/4
0%
0 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (100)
Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber
Role: lead
Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
Role: lead
Unruptured Cerebral Aneurysm: Prediction of Evolution
Role: collaborator
PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Role: collaborator
Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment.
Role: lead
Impact of Relaxation Sessions Using a Virtual Reality Application on the Sleep Quality of Caregivers Working Night Shifts
Role: lead
Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas
Role: lead
Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Correlates
Role: lead
Anticipating Depressive and Manic Episodes in Bipolar Disorders Using Vocal Biomarkers
Role: lead
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
Role: lead
Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)
Role: lead
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
Role: lead
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
Role: lead
Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy
Role: lead
Association Between the Quality of the Therapeutic Alliance and the Response to ChronoS Therapy
Role: lead
Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder
Role: lead
Evaluation of the ChronoS Therapy on the Severity of Sleep Disturbances Among Patients With Mood Disorders: A Within-subjects Study
Role: lead
Transfusion Exchanges and Cognition in Sickle Cell Disease
Role: lead
Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage
Role: lead
Can Cognitive Behavioural Therapy Help Incarcerated Men Quit Smoking? Efficacy and Predictors of Treatment Outcomes
Role: lead